Skip Navigation



Hum. Reprod. Advance Access published online on February 15, 2007

Human Reproduction, doi:10.1093/humrep/dem007
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
22/5/1239    most recent
dem007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vanhoutte, L.
Right arrow Articles by Van der Elst, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanhoutte, L.
Right arrow Articles by Van der Elst, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Nuclear and cytoplasmic maturation of in vitro matured human oocytes after temporary nuclear arrest by phosphodiesterase 3-inhibitor

Leen Vanhoutte1,3, Petra De Sutter1, Daniela Nogueira2, Jan Gerris1, Marc Dhont1 and Josiane Van der Elst1,{dagger},

1 Infertility Centre, Ghent University Hospital, Ghent, Belgium 2 Laboratoire de Biologie de la Reproduction, IFREARES, Toulouse, France

3 To whom correspondence should be addressed at: Infertility Centre, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. E-mail: leen.vanhoutte{at}ugent.be

BACKGROUND: The use of hormones for controlled ovarian stimulation results in follicular heterogeneity, with oocytes at diverse stages of nuclear and cytoplasmic development. This study evaluated the impact of temporary nuclear arrest by a specific phosphodiesterase 3-inhibitor (PDE3-I), cilostamide, on nuclear and cytoplasmic maturation of cumulus-free germinal vesicle (GV) human oocytes from controlled ovarian stimulated cycles. METHODS: GV oocytes (n = 234) were cultured in: (i) medium without the inhibitor (control); (ii) medium supplemented with 1 µM cilostamide and (iii) medium supplemented with 10 µM cilostamide. Oocytes in groups (ii) and (iii) were exposed to cilostamide for 24 h. The PDE3-I was subsequently removed by transfer of oocytes to fresh in vitro maturation (IVM) medium and the reversibility of GV arrest was assessed during IVM culture for maximum 48 h. RESULTS: Cilostamide (1 and 10 µM) could maintain >80% of the oocytes at the GV stage, without affecting subsequent maturation to metaphase II. Oocytes exposed to 1 µM cilostamide were more likely to have normal bipolar spindles with aligned chromosomes than control oocytes (P < 0.05). When GV chromatin configurations before and after arrest were compared, a significantly higher proportion of oocytes had acquired a nucleolus completely surrounded by a rim of highly condensed chromatin (P < 0.05). CONCLUSIONS: Temporary nuclear arrest of human GV oocytes with PDE3-I proved to be beneficial for obtaining normal spindle and chromosome configurations after IVM. It resulted also in synchronization within the population of GV oocytes.

Key words: in vitro maturation/meiosis/oocyte maturation/phosphodiesterases/spindle


{dagger} Present address: Centre for Reproductive Medicine, Dutch-speaking Brussels Free University Hospital, Brussels, Belgium.

This paper was presented at the 22nd Annual Meeting of the European Society of Human Reproduction and Embryology, Prague, June 18–21, 2006.

Submitted on August 28, 2006; resubmitted on October 27, 2006; resubmitted on December 29, 2006; accepted on January 5, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
M. Zuccotti, V. Merico, L. Sacchi, M. Bellone, T. C. Brink, M. Stefanelli, C. A. Redi, R. Bellazzi, J. Adjaye, and S. Garagna
Oct-4 regulates the expression of Stella and Foxj2 at the Nanog locus: implications for the developmental competence of mouse oocytes
Hum. Reprod., September 1, 2009; 24(9): 2225 - 2237.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Vanhoutte, D. Nogueira, F. Dumortier, and P. De Sutter
Assessment of a new in vitro maturation system for mouse and human cumulus-enclosed oocytes: three-dimensional prematuration culture in the presence of a phosphodiesterase 3-inhibitor
Hum. Reprod., August 1, 2009; 24(8): 1946 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Vanhoutte, D. Nogueira, and P. De Sutter
Prematuration of human denuded oocytes in a three-dimensional co-culture system: effects on meiosis progression and developmental competence
Hum. Reprod., March 1, 2009; 24(3): 658 - 669.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. DiLuigi, V. N. Weitzman, M. C. Pace, L. J. Siano, D. Maier, and L. M. Mehlmann
Meiotic Arrest in Human Oocytes Is Maintained by a Gs Signaling Pathway
Biol Reprod, April 1, 2008; 78(4): 667 - 672.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y.-m. Shu, H.-t. Zeng, Z. Ren, G.-l. Zhuang, X.-y. Liang, H.-w. Shen, S.-z. Yao, P.-q. Ke, and N.-n. Wang
Effects of cilostamide and forskolin on the meiotic resumption and embryonic development of immature human oocytes
Hum. Reprod., March 1, 2008; 23(3): 504 - 513.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.